Westwood Holdings Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$601K Buy
+2,782
New +$532K ﹤0.01% 416
2023
Q4
– Sell
-2,683
Closed -$690K – 459
2023
Q3
$690K Sell
2,683
-110
-4% -$29.4K 0.01% 368
2023
Q2
$796K Hold
2,793
– – 0.01% 359
2023
Q1
$777K Hold
2,793
– – 0.01% 375
2022
Q4
$773K Buy
+2,793
New +$789K 0.01% 376

Other funds holding BIIB

Westwood Holdings Group's BIIB Position: Q2 2026 in Review

Westwood Holdings Group opened a new position in Biogen (BIIB) in Q2 2026: 2,782 shares worth $601K. The stake represents ﹤0.01% of the portfolio and ranks #416 among its holdings. This is a return to the name: Westwood Holdings Group previously reported a position in BIIB as recently as Q3 2023.

Westwood Holdings Group first reported a position in BIIB in Q4 2022 and has held it in 5 quarters since. The position peaked at $796K in Q2 2023. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Westwood Holdings Group held 2,782 shares of Biogen worth $601K as of Q2 2026.
  • Biogen was a new Westwood Holdings Group position in Q2 2026.
  • Biogen made up ﹤0.01% of Westwood Holdings Group's portfolio in Q2 2026, its #416 holding.
  • Westwood Holdings Group first reported a position in Biogen in Q4 2022 and has held it in 5 quarters since.
  • Westwood Holdings Group's Biogen position peaked at $796K in Q2 2023.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Westwood Holdings Group's 13F filing for Q2 2026, filed 14 Aug 2026.